Published in J Exp Med on September 01, 1980
Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology (1968) 24.83
T cell control of antibody production. Contemp Top Immunobiol (1974) 8.38
Studies on hypersensitivity. II. Delayed hypersensitivity to denatured proteins in guinea pigs. Immunology (1959) 4.88
The immune response genes of the major histocompatibility complex. Immunol Rev (1978) 3.61
T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06
Determinant selection is a macrophage dependent immune response gene function. Nature (1977) 2.85
T-T interactions in the induction of suppressor and helper T cells: analysis of membrane phenotype of precursor and amplifier cells. J Exp Med (1977) 2.22
Fine specificity of regulatory T cells. II. Suppressor and helper T cells are induced by different regions of hen egg-white lysozyme in a genetically nonresponder mouse strain. J Exp Med (1979) 2.12
Different functional specificity repertoires for suppressor and helper T cells. Immunol Rev (1978) 1.91
Lysozyme-induced T-suppressor cells and antibodies have a predominant idiotype. Nature (1979) 1.40
Fine specificity of the H-2 linked immune response gene for the gallinaceous lysozymes. Eur J Immunol (1975) 1.37
Functional heterogeneity among the T-derived lymphocytes of the mouse. III. Helper and suppressor T-cells activated by concanavalin A. Cell Immunol (1975) 1.30
The fine specificity of regulatory T cells. I. Hen egg-white lysozyme-induced suppressor T cells in a genetically nonresponder mouse strain do not recognize a closely related immunogenic lysozyme. J Immunol (1979) 1.04
Specific suppressor responses to antigen under I region control. Fed Proc (1979) 1.00
The cellular basis of cross-tolerance. J Immunol (1973) 0.93
Multiple H-2 and non-H-2 genes controlling the antilysozyme response: alternative gene constellations can lead to responsiveness. Eur J Immunol (1980) 0.92
Suppressor cells in tolerance to HGG: kinetics and cross-suppression in high dose tolerance--absence in low dose tolerance. J Immunol (1977) 0.91
A miniaturized in vitro diffusion culture system. J Immunol Methods (1978) 0.87
Partial overlap of Ir gene-controlled responses to two proteins of limited relatedness: hen egg-white lysozyme and human lysozyme. Ann Immunol (Paris) (1980) 0.79
A physical map of the human genome. Nature (2001) 12.39
Chlamydial infection. Isolation of Chlamydia from patients with non-specific genital infection. Br J Vener Dis (1972) 7.92
E-cadherin germline mutations in familial gastric cancer. Nature (1998) 6.72
Mechanisms of lactose utilization by lactic acid streptococci: enzymatic and genetic analyses. J Bacteriol (1970) 6.34
Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev (2000) 5.80
The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol (1998) 5.50
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature (1992) 5.47
Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature (1993) 5.47
The antigenic structure of proteins: a reappraisal. Annu Rev Immunol (1984) 5.31
Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell (1988) 4.47
Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol (1993) 4.23
Rapid diagnosis of pulmonary tuberculosis by using Roche AMPLICOR Mycobacterium tuberculosis PCR test. J Clin Microbiol (1995) 4.11
Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol (1994) 4.07
Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med (1997) 4.04
1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol (2000) 3.82
Age differences in the frontal lateralization of verbal and spatial working memory revealed by PET. J Cogn Neurosci (2000) 3.66
Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today (1993) 3.62
Chlamydial infections of the cervix. Br J Vener Dis (1974) 3.48
IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol (1998) 3.37
Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke (1997) 3.26
Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol (2007) 3.24
Older paternal age and fresh gene mutation: data on additional disorders. J Pediatr (1975) 2.97
Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med (1990) 2.97
Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology (1995) 2.90
Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis (1983) 2.83
Critical care delivery in the intensive care unit: defining clinical roles and the best practice model. Crit Care Med (2001) 2.76
Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol (2001) 2.75
Surgical complication outcome (SCOUT) score: a new method to evaluate quality of care in vascular surgery. J Vasc Surg (1997) 2.67
The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site. Immunol Rev (1987) 2.56
Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis (2001) 2.51
Effect of tumor necrosis factor alpha on mitogen-activated human B cells. J Exp Med (1987) 2.42
Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J Biol Chem (2000) 2.37
Cell wall and protoplast isoperoxidases in relation to injury, indoleacetic Acid, and ethylene effects. Plant Physiol (1974) 2.36
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. Neurology (2012) 2.34
Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med (1995) 2.29
Quasi-hexagonal molecular packing in collagen fibrils. Nature (1980) 2.28
Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol (1984) 2.25
Why peptides? Their possible role in the evolution of MHC-restricted T-cell recognition. Immunol Today (1989) 2.23
Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol (1989) 2.22
A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. N Engl J Med (1987) 2.21
The X-Y-Z scheme of immunocyte maturation. 3. Early IgM memory and the nature of the memory cell. J Immunol (1967) 2.16
Fine specificity of regulatory T cells. II. Suppressor and helper T cells are induced by different regions of hen egg-white lysozyme in a genetically nonresponder mouse strain. J Exp Med (1979) 2.12
Phonons and the elastic moduli of collagen and muscle. Nature (1977) 2.09
Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr (1976) 2.00
The present status of the heterogeneity of fetal hemoglobin in beta-thalassemia: an attempt to unify some observations in thalassemia and related conditions. Ann N Y Acad Sci (1974) 1.99
Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weight-concerned women. J Consult Clin Psychol (2001) 1.99
Determination of the elastic constants of collagen by Brillouin light scattering. J Mol Biol (1979) 1.97
Changes in pulmonary function in workers exposed to vinyl chloride and polyvinyl chloride. Ann N Y Acad Sci (1975) 1.95
Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol (1996) 1.92
Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol Psychiatry (2005) 1.91
Different functional specificity repertoires for suppressor and helper T cells. Immunol Rev (1978) 1.91
The asynchronous development of immunological memory in helper (T) and precursor (B) cell lines. Eur J Immunol (1971) 1.91
Mean and instantaneous expiratory flows, FVC and FEV1: prediction equations from a probability sample of Michigan, a large industrial state. Bull Eur Physiopathol Respir (1987) 1.88
Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol (2001) 1.82
Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A (2001) 1.81
The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J Exp Med (1993) 1.80
Monocular elevation weakness and ptosis: an oculomotor fascicular syndrome? J Clin Neuroophthalmol (1991) 1.78
Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol Today (2000) 1.77
Audit of emergency preoperative resuscitation. Br J Surg (1994) 1.73
Volatile compounds produced in sterile fish muscle (Sebastes melanops) by Pseudomonas perolens. Appl Microbiol (1973) 1.73
Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest (1993) 1.73
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol (1997) 1.72
Structure of insect fibrillar flight muscle in the presence and absence of ATP. J Mol Biol (1972) 1.70
Analysis of the primary structure of collagen for the origins of molecular packing. J Mol Biol (1973) 1.68
Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med (1999) 1.68
The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol (1998) 1.65
A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer. Br J Cancer (2011) 1.65
Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J Exp Med (1989) 1.65
Interpretation of the meridional X-ray diffraction pattern from collagen fibres in terms of the known amino acid sequence. J Mol Biol (1977) 1.64
Capacity of intact proteins to bind to MHC class II molecules. J Immunol (1989) 1.63
Molecular conformation and packing in collagen fibrils. J Mol Biol (1983) 1.62
Epitope specificity of the T cell proliferative response to lysozyme: proliferative T cells react predominantly to different determinants from those recognized by B cells. Eur J Immunol (1980) 1.62
Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice. J Exp Med (1996) 1.61
Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. J Immunol (1987) 1.60
Asbestos exposure of brake repair workers in the United States. Mt Sinai J Med (1976) 1.59
Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med (1999) 1.58
Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant. J Exp Med (1996) 1.58
Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity. J Immunol (1993) 1.57
Shifting linear growth during infancy: illustration of genetic factors in growth from fetal life through infancy. J Pediatr (1976) 1.55
Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients. Ann Neurol (2001) 1.55
The Ontario Mental Health Act, 1978. A comment on its application. Can J Psychiatry (1979) 1.55
A randomised comparison of SurePath liquid-based cytology and conventional smear cytology in a colposcopy clinic setting. BJOG (2008) 1.55
Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed) (1983) 1.55
Induction of anti-self-immunity to cure cancer. Cell (1995) 1.54
The control of T cell responses by dendritic cell subsets. Curr Opin Immunol (2000) 1.53
Interaction of asbestos, age, and cigarette smoking in producing radiographic evidence of diffuse pulmonary fibrosis. Am J Med (1986) 1.53
The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today (1995) 1.51
The in situ supermolecular structure of type I collagen. Structure (2001) 1.50
Molecular packing in type I collagen fibrils. J Mol Biol (1987) 1.49
The closing of a social HMO: a case study. J Aging Soc Policy (1998) 1.49
A review of water quality concerns in livestock farming areas. Sci Total Environ (2000) 1.48
Neonatal T-cell tolerance to minimal immunogenic peptides is caused by clonal inactivation. Nature (1986) 1.47